Description
*All items contained in this section are blends. They contain both compounds listed in one vial. You will receive one vial per order.
(Mix) CJC 1295 w/o DAC with GHRP-2
The peptide CJC 1295 W/o DAC With GHRP-2 is a combination of the peptide CJC 1295 with no DAC (that is, Drug Affinity Complex) and GHRP-2.
Blend Overview
According to scientific study based on animal test subjects, CJC 1295 W/o DAC With GHRP-2’s functionality ties into the operational mechanics of the two peptides on an individual basis. CJC 1295 W/o DAC works to extend the half-life of a peptide chain known as GHRH1-29, which is a key component that essentially allows for the regulation and control of several endocrine system-related bodily functions such as growth and metabolism. GHRP-2, on the other hand, has been shown to have the capacity to boost the secretions from somatrophic cells which are located within an animal test subject’s pituitary gland; these particular cells are charged with the regulation and control of an animal test subject’s growth.
Because of the different functions that the two peptides bring to the table separately, scientific study based on animal test subjects have determined that CJC 1295 W/o DAC With GHRP-2 could contain several theoretical benefits relating to an increased level of bodily efficiency, which in turn could make it easier for homeostasis to be properly achieved. Some of these benefits include an increased rate of muscle mass proliferation, an elevated rate of injury recovery, and a boosted means of lipolysis.
Purely for Scientific Research
Although there has been plenty of research on CJC 1295 W/o DAC With GHRP-2 relating to how it functions, it needs to be emphasized that the peptide is still just intended for scientific study. As such, any findings or observations relating to CJC-1295 No DAC’s overall functionality, mechanics, or benefits should simply be the product of study exclusively performed within a strictly contained environment such as a laboratory or a medical research facility.
